NYSE : CNMD
-$2.21 (-4.91%)
NYSE
Patrick J. Beyer
Medical - Devices
Healthcare
CNMD
3900
US
USD
0.85
2.29
1.04
0.12
0.34
$1.37B
0.94
1.29
10.42
4.04
$1.51
$47.06M
4.00%
5.96%
5.40%
2.37%
24.15
-0.45
-0.45
$37.50
$39.00
$36.00
3/5
21 Analysts
14.13%
About CONMED Corporation (NYSE:CNMD) Stock
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONM ... ED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
2026-07-02 16:05:00
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2026 after the market close on Wednesday, July 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer
2026-06-17 16:35:00
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. “We are pleased to welcome a talented and experienced financial executive of John's caliber to CONMED,” said Patrick J. Beyer, CONMED's President and Chief Executive Officer. “John brings deep healthcare and.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
2026-06-01 10:25:46
CNMD is sharpening its focus on AirSeal, Buffalo Filter and BioBrace, betting on higher-growth platforms to drive margin gains and long-term growth.
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?
2026-05-29 12:32:02
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
2026-05-25 12:16:05
CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
2026-05-20 09:00:00
CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (âBoardâ), effective July 1, 20
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
2026-05-20 08:30:00
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (“Board”), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mr. Mirviss will serve as a member of the Compensation Committee and the Corporate Governance and Nominating Committee. In connection with these appointments, CONMED is increasing the size of its Board to include a total.
Is the Options Market Predicting a Spike in CONMED Stock?
2026-05-14 12:01:23
Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
Frequently Asked Questions
What is the current CONMED Corporation (CNMD) stock price?
CONMED Corporation(NYSE:CNMD) stock price is $42.8 in the last trading session. During the trading session, CNMD stock reached the peak price of $56.64 while $31.44 was the lowest point it dropped to. The percentage change in CNMD stock occurred in the recent session was --4.91% while the dollar amount for the price change in CNMD stock was -$2.21.
CNMD's industry and sector of operation?
The NYSE listed CNMD is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of CNMD?
Hollie Foust
| Executive Vice President, General Counsel and Corporate Secretary
Curt R. Hartman
| Special Advisor
John Ferrell
| Executive Vice President of Human Resources
Patrick J. Beyer
| President, CEO, Interim Principal Financial Officer & Director
Kimberly A. Lockwood
| Interim Corporate Controller & Interim Principal Accounting Officer
How many employees does CNMD have?
Number of CNMD employees currently stands at 3900. CNMD operates from 11311 Concept Boulevard, Largo, FL 33773-4908, US.
Link for CNMD official website?
Official Website of CNMD is: https://www.conmed.com
How do I contact CNMD?
CNMD could be contacted at phone #727 392 6464 and can also be accessed through its website. CNMD operates from 11311 Concept Boulevard, Largo, FL 33773-4908, US.
How many shares of CNMD are traded daily?
The average number of CNMD shares traded daily for last 3 months was 595.34K.
What is the market cap of CNMD currently?
The market value of CNMD currently stands at $1.29B with its latest stock price at $42.8